SymBio
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (22)
A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
Started: 3/17/2026
Phase III Study of SyB L-0501 in Combination With Rituximab to Treat Recurrent/Relapsed Diffuse Large B-Cell Lymphoma
Started: 1/15/2018
Study of SyB P-1501 (Fentanyl HCI) for Treatment of Postoperative Pain
Started: 11/21/2016
A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection
Started: 8/16/2021
Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation
Started: 10/14/2022
Efficacy and Safety Study of SyB L-0501 for Patients With Chronic Lymphocytic Leukemia
Started: 1/1/2013
Efficacy and Safety Study of SyB L-0501 in Combination With Rituximab in Patients With Untreated, Low-grade B Cell Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma
Started: 11/1/2011
Study of SyB L-0501 to Treat Relapsed/Refractory Multiple Myeloma
Started: 11/1/2011
Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)
Started: 5/1/2011
Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Started: 4/1/2010
Efficacy and Safety Study of SyB L-0501 for Patients With Multiple Myeloma
Started: 9/1/2010
A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma
Started: 6/9/2025
Phase I/II Study of SyB L-0501RI in Combination With Rituximab to Treat Lymphoma
Started: 4/1/2019
Safety and Pharmacokinetics Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS)
Started: 3/1/2013
Safety and Pharmacokinetics Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS)
Started: 6/1/2012
Combination Therapy of SyB C-1101 and Azacytidine in Patients With Myelodysplastic Syndrome
Started: 12/1/2015
Study of SyB C-1101 in Patients With Myelodysplastic Syndrome
Started: 10/6/2017
A Phase I Clinical Trial of SyB L-0501 in Combination With Rituximab to Patients With Aggressive B-cell Non-Hodgkin's Lymphoma
Started: 11/1/2008
SyB C-0501(Oral Bendamustine) in Patients With Advanced Solid Tumors
Started: 5/24/2018
Drug-Drug Interaction Study of Intravenous Administration of SyB V-1901 and Cyclosporine in Japanese Healthy Subjects
Started: 11/9/2020
Long Term Safety Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) - Extension Study
Started: 12/1/2014
Long Term Safety Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) - Extension Study
Started: 8/1/2013